Literature DB >> 19147768

Polyphenon E inhibits the growth of human Barrett's and aerodigestive adenocarcinoma cells by suppressing cyclin D1 expression.

Shumei Song1, Koyamangalath Krishnan, Kaifeng Liu, Robert S Bresalier.   

Abstract

PURPOSE: Green tea consumption has been shown to exhibit cancer-preventive activities in preclinical studies. Polyphenon E (Poly E) is a well-defined green tea-derived catechin mixture. This study was designed to determine the effects of Poly E on the growth of human Barrett's and aerodigestive adenocarcinoma cells and the mechanisms involved in growth regulation by this agent. EXPERIMENTAL
DESIGN: Human adenocarcinoma cells and immortalized Barrett's epithelial cells were used as model systems.
RESULTS: Poly E inhibited the proliferation of immortalized Barrett's cells as well as various adenocarcinoma cells, and this was associated with the down-regulation of cyclin D1 protein expression. Inhibition of cyclin D1 led to dephosphorylation of the retinoblastoma protein in a dose-dependent manner; these changes were associated with G(1) cell cycle arrest. Poly E down-regulated cyclin D1 promoter activity and mRNA expression, suggesting transcriptional repression, and this correlated with decreased nuclear beta-catenin and beta-catenin/TCF4 transcriptional activity. MG132, an inhibitor of 26S proteosome, blocked the Poly E-induced down-regulation of cyclin D1, and Poly E promoted cyclin D1 polyubiquitination, suggesting that Poly E also inhibits cyclin D1 expression by promoting its degradation.
CONCLUSION: Poly E inhibits growth of transformed aerodigestive epithelial cells by suppressing cyclin D1 expression through both transcriptional and posttranslational mechanisms. These results provide insight into the mechanisms by which Poly E inhibits growth of Barrett's and adenocarcinoma cells, and provides a rationale for using this agent as a potential chemopreventive and therapeutic strategy for esophageal adenocarcinoma and its precursor, Barrett's esophagus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19147768      PMCID: PMC2925407          DOI: 10.1158/1078-0432.CCR-08-0772

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  37 in total

1.  Upregulation of heme oxygenase-1 by Epigallocatechin-3-gallate via the phosphatidylinositol 3-kinase/Akt and ERK pathways.

Authors:  C C Wu; M C Hsu; C W Hsieh; J B Lin; P H Lai; B S Wung
Journal:  Life Sci       Date:  2005-12-27       Impact factor: 5.037

2.  EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells.

Authors:  Masahito Shimizu; Atsuko Deguchi; Andrew K Joe; Judith F Mckoy; Hisataka Moriwaki; I Bernard Weinstein
Journal:  J Exp Ther Oncol       Date:  2005

Review 3.  D-type cyclins.

Authors:  C J Sherr
Journal:  Trends Biochem Sci       Date:  1995-05       Impact factor: 13.807

4.  Esophageal cancer.

Authors:  Nimish Vakil; Aboud Affi
Journal:  Curr Opin Gastroenterol       Date:  2002-07       Impact factor: 3.287

5.  Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice.

Authors:  T C Wang; R D Cardiff; L Zukerberg; E Lees; A Arnold; E V Schmidt
Journal:  Nature       Date:  1994-06-23       Impact factor: 49.962

6.  Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma.

Authors:  N Nishida; Y Fukuda; T Komeda; R Kita; T Sando; M Furukawa; M Amenomori; I Shibagaki; K Nakao; M Ikenaga
Journal:  Cancer Res       Date:  1994-06-15       Impact factor: 12.701

7.  Expression of Egr-1, c-fos and cyclin D1 in esophageal cancer and its precursors: An immunohistochemical and in situ hybridization study.

Authors:  Ming-Yao Wu; Chu-Xiang Zhuang; Huan-Xing Yang; Ying-Rui Liang
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

8.  Green tea consumption and prostate cancer risk in Japanese men: a prospective study.

Authors:  Norie Kurahashi; Shizuka Sasazuki; Motoki Iwasaki; Manami Inoue; Shoichiro Tsugane
Journal:  Am J Epidemiol       Date:  2007-09-29       Impact factor: 4.897

9.  Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining.

Authors:  C Gillett; V Fantl; R Smith; C Fisher; J Bartek; C Dickson; D Barnes; G Peters
Journal:  Cancer Res       Date:  1994-04-01       Impact factor: 12.701

10.  Extended lifespan of Barrett's esophagus epithelium transduced with the human telomerase catalytic subunit: a useful in vitro model.

Authors:  M Corinna A Palanca-Wessels; Aloysius Klingelhutz; Brian J Reid; Thomas H Norwood; Kent E Opheim; Thomas G Paulson; Ziding Feng; Peter S Rabinovitch
Journal:  Carcinogenesis       Date:  2003-05-09       Impact factor: 4.944

View more
  9 in total

Review 1.  Risk factors for neoplastic progression in Barrett's esophagus.

Authors:  Elizabeth F Wiseman; Yeng S Ang
Journal:  World J Gastroenterol       Date:  2011-08-28       Impact factor: 5.742

2.  Phase Ib Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Patients with Barrett's Esophagus.

Authors:  Andrew K Joe; Felice Schnoll-Sussman; Robert S Bresalier; Julian A Abrams; Hanina Hibshoosh; Ken Cheung; Richard A Friedman; Chung S Yang; Ginger L Milne; Diane D Liu; J Jack Lee; Kazeem Abdul; Michelle Bigg; Jessica Foreman; Tao Su; Xiaomei Wang; Aqeel Ahmed; Alfred I Neugut; Esther Akpa; Scott M Lippman; Marjorie Perloff; Powel H Brown; Charles J Lightdale
Journal:  Cancer Prev Res (Phila)       Date:  2015-10-15

3.  Dietary Risk Reduction Factors for the Barrett's Esophagus-Esophageal Adenocarcinoma Continuum: A Review of the Recent Literature.

Authors:  Jessica L Petrick; Nan Li; Kathleen M McClain; Susan E Steck; Marilie D Gammon
Journal:  Curr Nutr Rep       Date:  2015-03-01

4.  A Novel YAP1 Inhibitor Targets CSC-Enriched Radiation-Resistant Cells and Exerts Strong Antitumor Activity in Esophageal Adenocarcinoma.

Authors:  Shumei Song; Min Xie; Ailing W Scott; Jiankang Jin; Lang Ma; Xiaochuan Dong; Heath D Skinner; Randy L Johnson; Sheng Ding; Jaffer A Ajani
Journal:  Mol Cancer Ther       Date:  2017-11-22       Impact factor: 6.261

5.  Dietary flavonoid intake and Barrett's esophagus in western Washington State.

Authors:  Jessica L Petrick; Susan E Steck; Patrick T Bradshaw; Wong-Ho Chow; Lawrence S Engel; Ka He; Harvey A Risch; Thomas L Vaughan; Marilie D Gammon
Journal:  Ann Epidemiol       Date:  2015-06-05       Impact factor: 3.797

6.  ABT-263 induces apoptosis and synergizes with chemotherapy by targeting stemness pathways in esophageal cancer.

Authors:  Qiongrong Chen; Shumei Song; Shaozhong Wei; Bin Liu; Soichiro Honjo; Ailing Scott; Jiankang Jin; Lang Ma; Haitao Zhu; Heath D Skinner; Randy L Johnson; Jaffer A Ajani
Journal:  Oncotarget       Date:  2015-09-22

Review 7.  Applications of a Standardized Green Tea Catechin Preparation for Viral Warts and Human Papilloma Virus-Related and Unrelated Cancers.

Authors:  Noriyuki Miyoshi; Hiroki Tanabe; Takuji Suzuki; Koichi Saeki; Yukihiko Hara
Journal:  Molecules       Date:  2020-06-02       Impact factor: 4.411

Review 8.  Inhibitory Effects of (-)-Epigallocatechin-3-gallate on Esophageal Cancer.

Authors:  Liu-Xiang Wang; Yun-Long Shi; Long-Jie Zhang; Kai-Rong Wang; Li-Ping Xiang; Zhuo-Yu Cai; Jian-Liang Lu; Jian-Hui Ye; Yue-Rong Liang; Xin-Qiang Zheng
Journal:  Molecules       Date:  2019-03-08       Impact factor: 4.411

9.  Overexpressed galectin-3 in pancreatic cancer induces cell proliferation and invasion by binding Ras and activating Ras signaling.

Authors:  Shumei Song; Baoan Ji; Vijaya Ramachandran; Huamin Wang; Margarete Hafley; Craig Logsdon; Robert S Bresalier
Journal:  PLoS One       Date:  2012-08-10       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.